TCW Group’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-14,088
Closed -$329K 723
2016
Q3
$329K Sell
14,088
-2,156
-13% -$48.9K ﹤0.01% 634
2016
Q2
$303K Buy
16,244
+1,978
+14% +$35.8K ﹤0.01% 653
2016
Q1
$259K Buy
+14,266
New +$230K ﹤0.01% 670
2015
Q3
Sell
-11,005
Closed -$373K 723
2015
Q2
$373K Sell
11,005
-4,223
-28% -$170K ﹤0.01% 644
2015
Q1
$732K Sell
15,228
-1,100
-7% -$49.9K ﹤0.01% 718
2014
Q4
$363K Sell
16,328
-82,485
-83% -$1.9M ﹤0.01% 714
2014
Q3
$1.87M Buy
98,813
+10,114
+11% +$241K 0.01% 673
2014
Q2
$2.39M Sell
88,699
-21,629
-20% -$548K 0.01% 642
2014
Q1
$3.57M Sell
110,328
-70,885
-39% -$2.3M 0.01% 570
2013
Q4
$4.32M Buy
+181,213
New +$5.07M 0.02% 530

Other funds holding FMI

TCW Group's FMI Position: Q4 2016 in Review

TCW Group sold out of Foundation Medicine, Inc. (FMI) in Q4 2016, closing a stake of 14,088 shares — an estimated $329K sold.

TCW Group first reported a position in FMI in Q4 2013 and held it in 10 quarters. The position peaked at $4.32M in Q4 2013. 95 funds tracked by Wall St. Rank hold FMI as of Q4 2016.

  • TCW Group reported no remaining Foundation Medicine, Inc. position as of Q4 2016 after selling out during the quarter.
  • TCW Group sold 14,088 Foundation Medicine, Inc. shares in Q4 2016, an estimated $329K.
  • TCW Group first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 10 quarters.
  • TCW Group's Foundation Medicine, Inc. position peaked at $4.32M in Q4 2013.
  • 95 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q4 2016.

Based on TCW Group's 13F filing for Q4 2016, filed 10 Feb 2017.